Dr. Jay Wang, M.D.
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Southern California Keck School of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,510
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: University of Southern California Keck School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
FL license ME101811 -
Hematology (Internal Medicine) Physician
FL license ME101811
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Naples Community Hospital Naples, FL
- Physicians Regional Medical Center - Pine Ridge Naples, FL
Medical groups
- Florida Cancer Specialists and Research Institute, LLC (498 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,510
- Services billed
- 615,107
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 129,540 | 105 |
| Injection, pembrolizumab, 1 mg | 38,200 | 31 |
| Injection, denosumab, 1 mg | 33,540 | 226 |
| Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 33,120 | 13 |
| Injection, azacitidine, 1 mg | 28,050 | 13 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 25,010 | 72 |
| Injection, aprepitant, 1 mg | 24,050 | 40 |
| Injection, nivolumab, 1 mg | 21,920 | 12 |
| Injection, oxaliplatin, 0.5 mg | 14,846 | 14 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,400 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Naples, FL | 275 |
| Hydroxyurea Other prescribers in Naples, FL | 151 |
| Ondansetron Odt (ondansetron) Other prescribers in Naples, FL | 115 |
| Eliquis (apixaban) Other prescribers in Naples, FL | 114 |
| Alprazolam Other prescribers in Naples, FL | 107 |
| Zolpidem Tartrate Other prescribers in Naples, FL | 98 |
| Oxycodone Hcl Other prescribers in Naples, FL | 88 |
| Revlimid (lenalidomide) | 85 |
| Xarelto (rivaroxaban) Other prescribers in Naples, FL | 70 |
| Levothyroxine Sodium Other prescribers in Naples, FL | 70 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 50 companies reported 247 payments worth $14,566 in total to this clinician.
| Jazz Pharmaceuticals Inc. | $7,257 |
|---|---|
| Deciphera Pharmaceuticals Inc. | $2,096 |
| AstraZeneca Pharmaceuticals LP | $601 |
| Pfizer Inc. | $421 |
| Novartis Pharmaceuticals Corporation | $352 |
| Merck Sharp & Dohme LLC | $291 |
| Incyte Corporation | $254 |
| Daiichi Sankyo Inc. | $236 |
| Compensation for services other than consulting (speaking, faculty) | $6,006 |
|---|---|
| Food and Beverage | $5,732 |
| Travel and Lodging | $1,536 |
| Honoraria | $1,275 |
| Education | $17.16 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) ZEPZELCA · HEMATOLOGY/ONCOLOGY | $6,006 |
| Deciphera Pharmaceuticals Inc. Mar 8, 2025 | Honoraria QINLOCK · ONCOLOGY | $1,275 |
| Deciphera Pharmaceuticals Inc. Mar 8, 2025 | Travel and Lodging QINLOCK · ONCOLOGY · travel to MIAMI, FL · in-kind | $372 |
| Jazz Pharmaceuticals Inc. Nov 14, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $361 |
| Deciphera Pharmaceuticals Inc. Mar 8, 2025 | Travel and Lodging QINLOCK · ONCOLOGY · travel to MIAMI, FL · in-kind | $329 |
| Jazz Pharmaceuticals Inc. Nov 14, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $226 |
| Jazz Pharmaceuticals Inc. Nov 14, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $157 |
| Jazz Pharmaceuticals Inc. Nov 15, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $43.51 |
| Jazz Pharmaceuticals Inc. Nov 24, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $28.00 |
| Jazz Pharmaceuticals Inc. Nov 24, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $19.60 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. Nov 24, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $28.00 |
| Jazz Pharmaceuticals Inc. Nov 24, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $19.60 |
| Jazz Pharmaceuticals Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) ZEPZELCA · HEMATOLOGY/ONCOLOGY | $6,006 |
| Jazz Pharmaceuticals Inc. Nov 15, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $43.51 |
| Jazz Pharmaceuticals Inc. Nov 14, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $361 |
| Jazz Pharmaceuticals Inc. Nov 14, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $226 |
| Jazz Pharmaceuticals Inc. Nov 14, 2025 | Travel and Lodging ZEPZELCA · HEMATOLOGY/ONCOLOGY · travel to Atlanta, GA · in-kind | $157 |
| Pfizer Inc. Mar 14, 2025 | Education ELREXFIO · ONCOLOGY · in-kind | $17.16 |
| Deciphera Pharmaceuticals Inc. Mar 8, 2025 | Honoraria QINLOCK · ONCOLOGY | $1,275 |
| Deciphera Pharmaceuticals Inc. Mar 8, 2025 | Travel and Lodging QINLOCK · ONCOLOGY · travel to MIAMI, FL · in-kind | $372 |
| Deciphera Pharmaceuticals Inc. Mar 8, 2025 | Travel and Lodging QINLOCK · ONCOLOGY · travel to MIAMI, FL · in-kind | $329 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.